Nora J. Besansky, the O'Hara Professor and Associate Chair in the Department of Biological Sciences, hypothesizes in a recent paper in the Proceedings of the National Academy of Sciences that if scientists can understand what makes a small group of Anopheles mosquito a strong malaria vector, then perhaps we can prevent the...

The Research Like A Champion (RLAC) Program is offering $12,500 to any and all students who are interested in cancer research. For those of you who are not familiar with the RLAC Program, it is a collaborative effort within the …

The β-lactams are a vast family of antibiotics that include the well-known penicillins; they remain the most widely administered antibiotics around the globe.  Results from this research could reveal new strategies for coping with the expanding scope of β-lactam resistance now happening among Gram-negative pathogens.

A new study looks to improve detection of falsified medications before they harm patients.

Chen Dai, University of Notre Dame graduate student of chemistry and biochemistry, was recognized at the Indiana University (IU) Simon Cancer Center’s annual Cancer Research Day. Dai received first prize for his poster presentation in the basic science – graduate student category.

The University of Notre Dame’s Science of Wellness Initiative (SWI) has announced the new Catalyst Seed Grant (CSG) Program. Full-time, regular Notre Dame faculty from all disciplines are encouraged to apply.

Join us for a campus-wide town hall event for the NDIIF.  The emphasis of the Town Hall will be on Research, Education, Partnership, and Impact. 

As part of a new study, researchers at the University of Notre Dame aim to create a more optimal computer network for solving complex problems — using heart cells.

Structured Immunity, a Notre Dame startup and biotechnology company specializing in the optimization and validation of T cell receptor (TCR) proteins, and Medigene AG, a leading biotechnology company engaged in the development of immunotherapies for the treatment of cancer, today announced a research collaboration where Structured Immunity will provide structural immunology expertise...

We are pleased to announce the awardees of the 2018 Walther Cancer Foundation Interdisciplinary Interface Training Program (IITP) grants. The IITP funding mechanism aims to establish cancer-focused integrative interdisciplinary training environment, provide support for highly qualified and productive applicants, and demonstrate efficacy of this training model to support future NIH...

A current cancer therapy is using T-cells and genetically engineering them to kill cancer, but these cells, known as CAR-T cells, have been known to attack off-target sites while completing their job. In order to counteract this negative effect, Notre Dame researchers are working to create nanoparticles that act as an...

The University of Notre Dame continued the steady expansion and growth of its research, scholarship, and creative endeavor programs during the most recent fiscal year (FY), recording $141.6 million in research funding. This surpasses the $138.1 million received in FY 2017. The amount is part of a trend that has...

The University of Notre Dame’s Master of Science in Global Health program celebrated its seventh graduating class on Saturday, July 28, 2018. This year’s cohort included over 20 students with diverse academic backgrounds and future career efforts.

Brian Baker, Rev. John A. Zahm Professor of Structural Biology at the University of Notre Dame, has received the Innovation Award from the American Cancer Society’s (ACS) local Coaches vs. Cancer program. The Innovation Award is described as being given to “an individual who demonstrates an innovative approach to treating...